148 related articles for article (PubMed ID: 19951323)
1. Identification and evaluation of false-negative antibody screens.
Powers A; Chandrashekar S; Mohammed M; Uhl L
Transfusion; 2010 Mar; 50(3):617-21. PubMed ID: 19951323
[TBL] [Abstract][Full Text] [Related]
2. [Screening of alloantibodies: stability of false positive results as a quality indicator].
Flourié F; Duboeuf S; Fay M; Garraud O
Ann Biol Clin (Paris); 2011; 69(4):470-2. PubMed ID: 21896414
[TBL] [Abstract][Full Text] [Related]
3. Risk of hemolytic transfusion reactions following emergency-release RBC transfusion.
Goodell PP; Uhl L; Mohammed M; Powers AA
Am J Clin Pathol; 2010 Aug; 134(2):202-6. PubMed ID: 20660321
[TBL] [Abstract][Full Text] [Related]
4. Polyethylene glycol antiglobulin tube versus gel microcolumn: influence on the incidence of delayed hemolytic transfusion reactions and delayed serologic transfusion reactions.
Winters JL; Richa EM; Bryant SC; Tauscher CD; Bendix BJ; Stubbs JR
Transfusion; 2010 Jul; 50(7):1444-52. PubMed ID: 20230534
[TBL] [Abstract][Full Text] [Related]
5. A retrospective analysis of the value of monocyte monolayer assay results for predicting the clinical significance of blood group alloantibodies.
Arndt PA; Garratty G
Transfusion; 2004 Sep; 44(9):1273-81. PubMed ID: 15318848
[TBL] [Abstract][Full Text] [Related]
6. Anti-AnWj causing acute hemolytic transfusion reactions in a patient with aplastic anemia.
Xu Z; Duffett L; Tokessy M; Cote J; Goldman M; Saidenberg E
Transfusion; 2012 Jul; 52(7):1476-81. PubMed ID: 22233405
[TBL] [Abstract][Full Text] [Related]
7. The suitability of hemolyzed specimens for compatibility testing using automated technology.
Laga A; Cheves T; Maroto S; Coutts M; Sweeney J
Transfusion; 2008 Aug; 48(8):1713-20. PubMed ID: 18482191
[TBL] [Abstract][Full Text] [Related]
8. Red blood cell alloimmunization in sickle cell disease patients in Uganda.
Natukunda B; Schonewille H; Ndugwa C; Brand A
Transfusion; 2010 Jan; 50(1):20-5. PubMed ID: 19821949
[TBL] [Abstract][Full Text] [Related]
9. Non-ABO red blood cell alloantibodies following allogeneic hematopoietic stem cell transplantation.
Franchini M; Gandini G; Aprili G
Bone Marrow Transplant; 2004 Jun; 33(12):1169-72. PubMed ID: 15094753
[TBL] [Abstract][Full Text] [Related]
10. Alloimmunization to red cell antigens in liver and multivisceral transplant patients.
Shariatmadar S; Pyrsopoulos NT; Vincek V; Noto TA; Tzakis AG
Transplantation; 2007 Aug; 84(4):527-31. PubMed ID: 17713438
[TBL] [Abstract][Full Text] [Related]
11. Transfusion therapy for autoimmune hemolytic anemia patients: a laboratory perspective.
Drouillard DD
Clin Lab Sci; 2008; 21(1):7-11. PubMed ID: 18335854
[TBL] [Abstract][Full Text] [Related]
12. Delayed and acute hemolytic transfusion reactions resulting from red cell antibodies and red cell-reactive HLA antibodies.
Takeuchi C; Ohto H; Miura S; Yasuda H; Ono S; Ogata T
Transfusion; 2005 Dec; 45(12):1925-9. PubMed ID: 16371045
[TBL] [Abstract][Full Text] [Related]
13. Anti-A antibody transfused with non-group-specific platelets. Serological abnormalities.
Thomas L; Tuscany FL; Wilner GD
Arch Pathol Lab Med; 1981 Jan; 105(1):52-3. PubMed ID: 6893913
[TBL] [Abstract][Full Text] [Related]
14. Red blood cell alloantibody frequency, specificity, and properties in a population of male military veterans.
Tormey CA; Fisk J; Stack G
Transfusion; 2008 Oct; 48(10):2069-76. PubMed ID: 18631165
[TBL] [Abstract][Full Text] [Related]
15. Coexistence of autoantibodies and alloantibodies to red blood cells due to blood transfusion.
Ahrens N; Pruss A; Kähne A; Kiesewetter H; Salama A
Transfusion; 2007 May; 47(5):813-6. PubMed ID: 17465945
[TBL] [Abstract][Full Text] [Related]
16. Red blood cell alloantibodies after transfusion: factors influencing incidence and specificity.
Schonewille H; van de Watering LM; Loomans DS; Brand A
Transfusion; 2006 Feb; 46(2):250-6. PubMed ID: 16441603
[TBL] [Abstract][Full Text] [Related]
17. A delayed hemolytic transfusion reaction (DHTR) with multiple alloantibodies (Anti-E, Jka, Dia, Fyb, and S) induced by E-antigen-negative, crossmatch-compatible blood.
Yamane K; Yagihashi A; Sasaki M; Kuwashima K; Morio A; Watanabe N
Immunopharmacol Immunotoxicol; 1998 Nov; 20(4):531-9. PubMed ID: 9805232
[TBL] [Abstract][Full Text] [Related]
18. Safety and impact of donor-type red blood cell transfusion before allogeneic peripheral blood progenitor cell transplantation with major ABO mismatch.
Scholl S; Klink A; Mügge LO; Schilling K; Höffken K; Sayer HG
Transfusion; 2005 Oct; 45(10):1676-83. PubMed ID: 16181220
[TBL] [Abstract][Full Text] [Related]
19. Impact of ABO incompatibility on allogeneic peripheral blood progenitor cell transplantation after reduced intensity conditioning.
Canals C; Muñiz-Díaz E; Martínez C; Martino R; Moreno I; Ramos A; Arilla M; Boto N; Pastoret C; Remacha A; Sierra J; Madoz P
Transfusion; 2004 Nov; 44(11):1603-11. PubMed ID: 15504166
[TBL] [Abstract][Full Text] [Related]
20. Root cause analysis of non-infectious transfusion complications and the lessons learnt.
Karim F; Moiz B; Shamsuddin N; Naz S; Khurshid M
Transfus Apher Sci; 2014 Feb; 50(1):111-7. PubMed ID: 24239270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
